Clinical studies suggest that chromium supplementation may be helpful for the following conditions:
Diabetes
The benefit of chromium supplements for diabetes has been studied and debated for a number of years. While some clinical studies have reported no beneficial effects of chromium use for people with diabetes, other clinical studies have reported that chromium supplements may reduce blood sugar levels as well as the amount of insulin needed by people with diabetes. Pregnancy-induced and steroid-induced diabetes are thought to benefit from chromium as well. Chromium was found to decrease the insulin resistance problems seen in individuals who smoke cigarettes. Chromium is an antioxidant, which helps protect the body against free radical damage (oxidation).
Because of the popularity of taking chromium supplements for blood sugar regulation, the U.S. Food and Drug Administration (FDA) reviewed the clinical evidence and concluded that the relationship between chromium picolinate intake and insulin resistance is highly uncertain. More clinical studies in this area are needed.
Obesity
Some clinical studies suggest that chromium may improve lean body mass (namely, muscle) and reduce body fat. However, despite the popularity of chromium (especially chromium picolinate) for weight loss, the effects are small compared to those of exercise and a well-balanced diet.
Strength training
Chromium is popular with some body builders and can be found in certain sports nutrition supplements. Despite this popularity, there is little clinical evidence that chromium supplementation changes body composition or helps people gain strength. This topic has been studied in several different groups of people, including athletic and nonathletic men and women as well as elderly men.
Heart health
Animal studies suggest that chromium may help improve blood pressure. This has yet to be tested on people. Until more information is available, use of chromium for this purpose is not currently recommended.
Although not all clinical studies agree, chromium has demonstrated the ability to lower total and low density lipoprotein (LDL or "bad") cholesterol levels and raise high density lipoproetin (HDL or "good") cholesterol levels in the blood, particularly in people with high cholesterol.
Chromium bound to niacin, or vitamin B3, has been reported in laboratory animal studies to be effective in protecting the heart and increasing energy levels.
Others
Chromium picolinate has been reported in preliminary clinical studies to improve symptoms of depression in people with atypical depression. Further clinical research is needed.
Dosages of chromium are based on the Dietary Guidelines for Americans 2005 published by the U.S. Department of Health and Human Services and U.S. Department of Agriculture. The recommended dietary allowances (RDAs) of chromium are as follows:
Pediatric
For infants birth - 6 months: The RDA for chromium is 0.2 mcg (micrograms) daily.
For infants 7 - 12 months: The RDA for chromium is 5.5 mcg daily.
For children 1 - 3 years: The RDA for chromium is 11 mcg daily.
For children 4 - 8 years: The RDA for chromium is 15 mcg daily.
For male children 9 - 13 years: The RDA for chromium is 25 mcg daily.
For female children 9 - 13 years: The RDA for chromium is 21 mcg daily.
For male children 14 - 18 years: The RDA for chromium is 35 mcg daily.
For female children 14 - 18 years: The RDA for chromium is 24 mcg daily.
For pregnant females 14 - 18 years: The RDA for chromium is 29 mcg daily.
For breast-feeding females 14 - 18 years: The RDA for chromium is 44 mcg daily.
Adult
For adult males 19 - 50 years: The RDA for chromium is 35 mcg daily.
For adult males 51 years and older: The RDA for chromium is 30 mcg daily.
For adult females 19 - 50 years: The RDA for chromium is 25 mcg daily.
For adult females 50 years and older: The RDA for chromium is 20 mcg daily.
For pregnant females 19 years and older: The RDA for chromium is 30 mcg daily.
For breast-feeding females 19 years and older: The RDA for chromium is 30 mcg daily.
Chromium supplementation
For disease prevention and treatment, dosage in adults is typically 200 mcg chromium, 1 - 3 times a day. Type 2 diabetics may benefit from doses as high as 1,000 mcg daily, but long term safety with such high doses is not known.
Anderson R. Chromium, glucose intolerance and diabetes. J Amer Coll Nutr. 1998;17:548-555.
Anderson RA. Chromium in the prevention and control of diabetes. Diabetes and Metabolism. 2000;26(1)22-27.
Anderson RA. Effects of chromium on body composition and weight loss. Nutr Rev. 1998;56(9):266-270.
Anderson R. Elevated intake of supplemental chromium improved glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997;46:1786-1791.
Anderson RA. Nutritional factors influencing the glucose/insulin system: chromium. J Am Coll Nutr. 1997;16(5):404-410.
Anderson RA, Cheng N, Bryden NA, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997;46:1,786–1,791.
Anderson RA, Roussell AM, Zouari N, Mahjoub S, Matheau JM, Kerkeni A. Potential antioxidant effects of zinc and chromium supplementation in people with type 2 diabetes mellitus. J Am Coll Nutr. 2001;20(3):212-218.
Bahadori B, Wallner S, Schneider H, Wascher TC, Toplak H. Effect of chromium yeast and chromium picolinate on body composition of obese, non-diabetic patients during and after a formula diet. Acta Med Austria Ca. 1997;24:185–187.
Blank HM, Khan LK, Serdula MK. Use of nonprescription weight loss products, results from a multistate survey. JAMA. 2001;286(8):930-935.
Broadhurst CL, Domenico P. Clinical studies on chromium picolinate supplementation in diabetes mellitus--a review. Diabetes Technol Ther. 2006;8(6):677-87.
Campbell WW, Joseph LJ, Davey SL, Cyr-Campbell D, Anderson RA, Evans WJ. Effects of resistance training and chromium picolinate on body composition and skeletal muscle in older men. J Appl Physiol. 1999;86(1):29-39.
Cheng HH, Lai MH, Hou WC, Huang CL. Antioxidant effects of chromium supplementation with type 2 diabetes mellitus and euglycemic subjects. J Agric Food Chem. 2004;52(5):1385-9.
Davis ML, Seaborn CD, Stoecker BJ. Effects of over-the-counter drugs on 51chromium retention and urinary excretion in rats. Nutr Res. 1995;15:201-210.
Dietary Guidelines for Americans 2005. Rockville, MD: US Dept of Health and Human Services and US Dept of Agriculture; 2005.
Frauchiger MT, Wenk C, Colombani PC. Effects of acute chromium supplementation on postprandial metabolism in healthy young men. J Am Coll Nutr. 2004;23(4):351-7.
Fujimoto S. Studies on the relationships between blood trace metal concentrations and the clinical status of patients with cerebrovascular disease, gastric cancer, and diabetes mellitus. Hokkaido Igaku Zasshi. 1987;62:913–932.
Gordon JB. An easy and inexpensive way to lower cholesterol? West J Med. 1991 Mar;154(3):352.
Gunton JE, Cheung NW, Hitchman R, Hams G, O'Sullivan C, Foster-Powell K, McElduff A. Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance. Diabetes Care. 2005;28(3):712-3.
Hermann J, Arquitt A, Stoecker B. Effects of chromium supplementation on plasma lipids, apolipoproteins, and glucose in elderly subjects. Nutr Res. 1994;14(5):671.674.
Institute of Medicine. Dietary Reference Intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press; 2004.
Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care. 1994;17:1449-1452.
Livolsi JM, Adams GM, Laguna PL. The effect of chromium picolinate on muscular strength an body composition in women athletes. J Strength Cond Res. 2001;15(2):161-166.
Lukasi HC, Bolonchuk WW, Siders, WA, Milne DB. Chromium supplementation and resistance training: effects on body composition, strength, and trace element status of men. Am J Clin Nut. 1996;663:954-965.
McCarty MF. Complementary measures for promoting insulin sensitivity in skeletal muscle. Med Hypotheses. 1998;51(6):451-464.
McCarty MF. Anabolic effects of insulin on bone suggests a role for chromium picolinate in preservation of bone density. Med Hypotheses. 1995;45:241–246.
McCarty MF. Chromium picolinate may favorably influence the vascular risk associated with smoking by combating cortisol-induced insulin resistance. Med Hypotheses. 2005;64(6):1220-4.
National Institutes of Health. NIH Program Announcement. Chromium as adjuvant therapy for type 2 diabetes and impaired glucose tolerence. NIH Guide. 2001. Accessed at http://www.nccam.nih.gov/nccam/fi/concepts/pa/pa-01-114.html on March 5, 2002.
Porter DJ, Raymond LW, Anastasio GD. Chromium: friend or foe? Arch Family Med. 1999;8(5):386-390.
Press RI, Geller J, Evans GW. The effect of chromium picolinate on serum cholesterol and apolipoprotein fractions in human subjects. Western J Med. 1993;152:41-45.
Preuss HG, Jarrell ST, Scheckenbach R, Lieberman S, Anderson RA. Comparative effects of chromium, vanadium and gymnema sylfestre on sugar-induced blood pressure elevations in SHR. J Am Coll Nutr. 1998;17(2):116-123.
Racek J, Trefil L, Rajdl D, Mudrova V, Hunter D, Senft V. Influence of chromium-enriched yeast on blood glucose and insulin variables, blood lipids, and markers of oxidative stress in subjects with type 2 diabetes mellitus. Biol Trace Elem Res. 2006;109(3):215-30.
Ravina A, Slezack L. Chromium in the treatment of clinical diabetes mellitus. Harefuah. 1993;125(5-6):142-145,191.
Ravina A, Slezak L, Mirsky N, Bryden NA, Anderson RA. Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium. Diabetic Med. 1999;169(2):164-167.
Ryan GJ, Wanko NS, Redman AR, Cook CB. Chromium as adjunctive treatment for type 2 diabetes. Ann Pharmacother. 2003;37(6):876-85.
Seaborn CD, Stoecker BJ. Effects of antacid or ascorbic acid on tissue accumulation and urinary excretion of chromium-51. Nutr Res. 1990;10:1401-1408.
Shannon M. Alternative medicines toxicology: a review of selected agents. Clin Tox. 1999;37(6):709-713.
Trow LG, Lewis J, Greenwood RH, Sampson MJ, Self KA, Crews HM, et al. Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin, and lipoprotein levels in patients with type 2 diabetes. Int J Vitam Nutr Res. 2000;70(1):14-18.
Trumbo PR, Ellwood KC. Chromium picolinate intake and risk of type 2 diabetes: an evidence-based review by the United States Food and Drug Administration. Nutr Rev. 2006;64(8):357-63.
Volpe SL, Huang HW, Larpadisorn K, Lesser II. Effect of chromium supplementation and exercise on body composition, resting metabolic rate and selected biochemical parameters in moderately obese women following an exercise program. J Am Coll Nutr. 2001;20(4):293-296.
Vincent JB. The biochemistry of chromium. J Nutr. 2000;130:715-718.
Wang MM. Serum cholesterol of adults supplemented with brewer's yeast or chromium chloride. Nutr Res. 1989;9:989-998.
Wilson BE, Gondy A. Effects of chromium supplementation on fasting insulin levels and lipid parameters in healthy, non-obese young subjects. Diabetes Res Clin Pract. 1995;28:179–184.